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mAbstract
Background: The surge in uptake of nasal continuous positive airway pressure (CPAP)
for respiratory support in preterm infants has occurred in the absence of an authentic
animal model. Such a model would allow investigation of research questions of
physiological and therapeutic importance. We therefore aimed to develop a preterm
lamb model of the non-intubated very preterm infant on CPAP.
Methods: After staged exteriorisation and instrumentation, preterm lambs were
delivered from anaesthetised ewes at 131 to 133 days gestation. Via a single nasal prong
(4-mm internal diameter, 6- to 7-cm depth), positive pressure was delivered from the
outset, with nasal intermittent positive pressure ventilation (NIPPV) used until transition
to nasal CPAP was attempted, and periodically thereafter for hypoventilation. Caffeine
and doxapram were used as respiratory stimulants. Gastric distension was prevented
with an oesophageal balloon. Cardiorespiratory parameters and results of arterial blood
gas analyses were monitored throughout the study period, which continued for 150 min
after first transition to CPAP.
Results: Ten preterm lambs were studied, at gestation 132 ± 1 days (mean ± SD)
and birth weight 3.6 ± 0.45 kg. After stabilisation on NIPPV, transition to nasal CPAP
was first attempted at 28 ± 11 min. There was transient respiratory acidosis, with
gradual resolution as spontaneous respiratory activity increased. In the final hour,
79% ± 33% of time was spent on CPAP alone, with typical respiratory rates around
60 breaths per minute. PaCO2 at end-experiment was 58 ± 36 mmHg.
Conclusions: Non-intubated preterm lambs can be effectively transitioned to nasal
CPAP soon after birth. This animal model will be valuable for further research.
Keywords: Preterm lamb; Continuous positive airway pressure; Non-invasive
positive pressure ventilation; ApnoeaBackground
Unlike many areas of intensive care practice, the surge in uptake of nasal continuous
positive airway pressure (CPAP) for respiratory support from birth in very preterm in-
fants <32 weeks gestation has occurred in the absence of an authentic, robust and ac-
cessible animal model. Such a model would allow the conduct of experimental studies
that are technically challenging and/or ethically unsound in human infants, and2015 Dargaville et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
ttribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any
edium, provided the original work is properly credited.
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pressure, the relative merits of CPAP delivery devices and the optimal approach to
nasal intermittent positive pressure ventilation (NIPPV). The physiological effects of
adjunctive therapies applied in infants on CPAP, including recruitment manoeuvres [1],
surfactant therapy [2,3] and caffeine [4,5], could also be more fully and systematically
evaluated.
In the past, experimental studies of CPAP in preterm animals have been undertaken at from
birth with an endotracheal tube in situ [6-9] or many hours after birth at a time when some
of the unique physiological features of the cardiorespiratory transition at birth have dissipated
[10,11]. Rahmel and co-workers recently described the first authentic animal model of nasal
CPAP applied from birth, using short binasal prongs in newborn preterm lambs at 136 days
gestation [12]. Their study demonstrates that CPAP delivery via a nasal interface is possible in
preterm lambs in the immediate newborn period and can be used for therapeutic trials. The
model has the limitations of the need for spinal anaesthesia in the pregnant ewe, the relatively
mature gestation, the use of a nasal CPAP interface that may be difficult to maintain in pos-
ition and a 20% mortality risk from respiratory failure within the first 30 min [12].
We wished to develop a robust model of nasal CPAP in preterm lambs delivered at a
less mature gestation (131 to 133 days) from ewes receiving general anaesthesia. We
aimed to evaluate whether, with a practical and effective CPAP delivery interface and
therapy to induce spontaneous breathing, nasal CPAP could be applied in the immedi-
ate newborn period and produce adequate tidal ventilation and gas exchange.Methods
Experimental approach
Studies were conducted within the animal research facility at the Murdoch Childrens Research
Institute. The study protocol was approved by the Murdoch Childrens Research Institute Ani-
mal Ethics Committee, and the experiments conducted according to the Australian Code for
the Care and Use of Animals for Scientific Purposes 2013. Date-mated Border-Leicester/Me-
rino ewes were treated with betamethasone (11.4 mg by intramuscular injection) 48 and 24 h
prior to delivery. On the day of the experiment, ewes were anaesthetised, intubated and venti-
lated, and venous and arterial catheters were inserted. Anaesthesia was maintained with intra-
venous propofol and nitrous oxide, along with isoflurane, which was used at the lowest
possible concentration, and turned off for 20 min prior to delivery. In the case of twin gestation,
anaesthesia was maintained for 2 to 3 h during which each fetus was sequentially instrumented
and delivered. After hysterotomy, the fetal head and neck was delivered, and arterial and ven-
ous catheters were placed in the neck vessels using a cutdown technique with local anaesthesia.
The fetal head was dried, and 10% lignocaine (Xylocaine spray, AstraZeneca, North Ryde,
Australia) was introduced into both nostrils and applied to the vocal cords under direct laryn-
goscopic vision.
The CPAP delivery interface was a single nasal prong (shortened size 4.0 tracheal tube,
Covidien, Mansfield, USA) positioned over a stylet to a depth of 6 to 7 cm [13], which based
on anatomical studies resulted in a tip position around 2 to 3 cm proximal to the epiglottis
(Figure 1). The choice of a single prong positioned deep in the nares was based on a) our
previous experience of the failure to achieve an adequate seal with a close-fitting mask (G.
Polglase, unpublished observations), b) the difficulties previously encountered in maintaining
Figure 1 Nasopharyngeal anatomy in the preterm lamb. Computed tomographic images of the snout
in a preterm lamb at 129 days gestation. (A) Parasagittal image showing dilatation of the nasal cavity deep within
the nasopharynx. Path of nasal CPAP prong indicated by dotted white line (depth 6.5 cm). (B) 3D reconstruction
of sagittal CT images; position of CPAP prong tip and epiglottis indicated by black and white arrows, respectively.
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shallower single prong position did not transmit applied airway pressure adequately to the
lung in the preterm lamb. Via the other nasal passage, a balloon-tipped catheter (size 10FG
Foley catheter, Covidien) was placed in the oesophagus over a guide wire, positioned 6 cm
below the cricoid cartilage, and the balloon was inflated with 3 mL saline to occlude the
oesophagus. A 10FG Replogle suction tube (Covidien) was also passed transnasally with
the tip immediately above the oesophageal balloon. The trachea was intubated with a
cuffed size 4.0 endotracheal tube (ETT), and a surfactant delivery catheter was also placed
in the trachea 9 cm below the vocal cords. After securing the tubes, the snout was
wrapped with elastic bandage (Coban, 3 M, St. Paul, MN, USA) to seal the mouth.
With placental support maintained, the fetal chest was delivered, lung liquid was
drained (expected recovery approximately 10 mL/kg) and respiratory inductance
Dargaville et al. Intensive Care Medicine Experimental  (2015) 3:13 Page 4 of 12plethysmography (RIP) bands were placed around the chest and abdomen [14,15]. Re-
cordings of RIP data, along with delivered airway pressure, were made continuously.
After cord clamping, the lamb was delivered, weighed and placed prone under a radi-
ant warmer. A sustained inflation at 40 cm H2O pressure was immediately applied for
20 s via the ETT [16]. The ETT was immediately withdrawn from the trachea, without
displacing the surfactant delivery catheter, clamped and left in situ in the oropharynx.
Nasal IPPV was then commenced via the single prong, with initial positive end-
expiratory pressure (PEEP) 8 cm H2O, peak pressure 30 cm H2O, inspiratory time
0.6 s, respiratory rate 30 bpm and FiO2 0.4. We found, as have others [12,17], that a
period of nasal IPPV was necessary to maintain gas exchange until spontaneous ventila-
tion was established. Caffeine (20 mg/kg caffeine base) and doxapram (5 mg/kg) were
administered to stimulate breathing [18], and a doxapram infusion was maintained at
2.5 mg/kg/h throughout.
Heart rate, blood pressure and oxygen saturation (SpO2) were monitored continuously,
as was respiratory rate (RR) using RIP. Arterial blood gas analyses were performed period-
ically. Nasal IPPV rate was reduced as soon as practicable, with the goal of transitioning
to support with CPAP alone within 30 min so long as respiratory rate and effort were
maintained, with pH >7.20 and PaCO2 < 65. In the event of hypoventilation or apnoea, re-
spiratory effort was promoted by cutaneous stimulation, repeated doxapram boluses
(1 mg/kg, maximum three doses) and, if necessary, reinstitution of nasal IPPV (rate 2 to
30 bpm). FiO2 was adjusted throughout to maintain SpO2 88% to 92% and PaO2 50 to
80 mm Hg. CPAP/PEEP was increased (max 10 cm H2O) if FiO2 > 0.6 and decreased
(minimum 6 cm H2O) if FiO2 < 0.25.
Body temperature was maintained at 38°C to 39°C. Infusions of 4% dextrose and
0.18% saline (intravenous) and heparinised saline (arterial) continued throughout. Mea-
sures to promote comfort included swaddling, intra-oral sucrose (2 mL prn) and tactile
soothing, along with ketamine (0.1 mg/kg prn) if unsettled. Oropharyngeal, nasopha-
ryngeal and oesophageal suction was performed at 15-min intervals.
Within 15 min of first transition to CPAP, all animals received surfactant (Curosurf
100 mg/kg) via the surfactant instillation catheter as part of a study investigating sur-
factant distribution, the results of which will be reported separately. Wherever possible,
the study continued for 150 min after initiation of CPAP, after which a lethal dose of
pentobarbital was administered.Data processing and analysis
Data recording, processing and analysis were undertaken using LabChart 7 (ADInstru-
ments Pty Ltd, Bella Vista, Australia). For each animal, values for physiological parameters
and arterial blood gas analyses were extracted 5 min after initiation of nasal IPPV (initial),
immediately prior to commencement of CPAP (pre-CPAP), and at 15, 30, 45, 60, 90, 120
and 150 min after first trial of CPAP. At each time point, the ventilator set rate (if on
NIPPV) was recorded, and the respiratory rate (mechanically assisted, spontaneous and
total) was counted in a 2-min time window. Breaths were defined as any discrete positive
deflection in chest and/or abdominal RIP voltage, and were counted using peak detection,
with manual checking. Breaths were deemed to be mechanically assisted if occurring
within 100 ms after onset of a positive pressure inflation. To overcome the limitations of
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last hour of recording for each animal.
Data are presented as mean and standard deviation (SD) unless otherwise stated. Dif-
ferences in parameters between time points were examined using repeated measures
ANOVA. Dunnett’s post hoc test was used to compare values at all other time points
with the pre-CPAP values.Results
Preliminary studies were performed in six animals (data not shown), in which the instru-
mentation techniques, approach to nasal IPPV and dosage of respiratory stimulants were
refined. The study group consisted of ten lambs in which the experimental strategy thus
developed was applied. An additional lamb in which prolonged need for resuscitation was
followed by early pneumothorax and demise at 90 min was not included. Study animals
were of gestation 132 ± 0.7 days (mean ± SD) and birth weight 3.6 ± 0.45 kg. Seven animals
(70%) were from twin gestations, and three (30%) were male. The pre-delivery instrumen-
tation procedure was performed without complication in all animals.
Transition from NIPPV to CPAP was first attempted at 28 ± 11 min of life. Duration of
the experiment thereafter was 165 ± 20 min, with lambs supported on CPAP alone for
113 ± 48 min (68% ± 28% of time). In the final hour, lambs were on CPAP 79% ± 33% of
the time. No lamb required endotracheal intubation; one lamb received NIPPV for all but
a few minutes due to hypoventilation and was found to have a pneumothorax on postmor-
tem examination. Data for this animal have been included in the analysis.
Most lambs showed the capacity for spontaneous respiration relatively soon after
birth, which in some cases was masked by the use of NIPPV. Once on CPAP, apnoea
events were common and were provoked in some cases by noxious stimuli including
suctioning and instillation of surfactant. Beyond the initial loading dose and infusion,
lambs received 1.6 ± 1.1 mg/kg doxapram as additional bolus doses (each 1 mg/kg) in
order to prevent apnoea, with an apparent benefit in most cases. Transient myoclonus
was observed in two lambs after repeated doxapram top-up dosing. As experience was
gained, a clear benefit of reinstituting nasal IPPV at very low rate (2 to 5 bpm) in miti-
gating apnoea was noted (see below).
Physical activity was noted to gradually increase during the course of the experiment.
Excess movement could generally be quelled with swaddling, tactile stimulation and
oral sucrose. Most lambs spent long periods breathing comfortably on CPAP. Ketamine
for apparent discomfort was administered to one animal.
Mean heart rate and blood pressure stabilised rapidly after delivery (Figure 2), were
unaltered during transition to CPAP and remained stable thereafter. Gas exchange was
readily achieved with nasal IPPV in early life. After attempted transition to CPAP, re-
spiratory acidosis and increased oxygen requirement were transiently noted, although
for all indices of gas exchange, the values at end-experiment were at or close to those
achieved initially (Figure 2). The final blood gas analysis was performed on CPAP only
(i.e. no NIPPV) in eight out of the ten animals.
Representative respiratory patterns during various phases of the experiment are
shown in Figures 3 and 4, and summary data for NIPPV requirements and respiratory
rates are shown in Table 1. Throughout the experiment, most NIPPV inflations resulted
Figure 2 Cardiorespiratory indices. Mean and SE for cardiorespiratory indices at each experimental time
point. Black arrow indicates the time of the first CPAP trial. (A) Heart rate, (B) mean blood pressure, (C) FiO2,
(D) arterial pH, (E) PaCO2 and (F) AaDO2. *Differs from pre-CPAP value, P < 0.05, ANOVA with Dunnett’s post
hoc test. CPAP, continuous positive airway pressure; AaDO2, alveolar-arterial oxygen difference.
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tion of NIPPV with a low set rate was seen to stimulate spontaneous breathing in some
cases (Figure 4A). Conversely, mechanical inflations appeared in some instances to
interrupt the cadence of spontaneous breathing (Figure 4B). After the first attempt at
transition to CPAP, spontaneous respiratory rate gradually increased and need for
NIPPV decreased (Table 1). In the entire final hour of data recording, RR was 59 ± 14
breaths per minute, with 88% ± 26% of breaths being spontaneous and supported only
with CPAP (Figure 4C).Discussion
In this study, we sought to develop a robust model of nasal CPAP in preterm lambs
131 to 133 days gestation. We found that following initial use of NIPPV, lambs could
be stabilised on nasal CPAP in the first hour of life, with a transient respiratory acidosis
that resolved as spontaneous respiratory activity increased. Most lambs were breathing
comfortably on CPAP during the last hour of the experiment.
Figure 3 (See legend on next page.)
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Figure 3 Respiratory patterns (I). Representative tracings of RIP voltage (top) and airway opening
pressure (bottom) during the experiment. Note differing time scales between panels. (A) Lamb 5 at 5 min
of life; full NIPPV support, no spontaneous breathing. (B) Lamb 5 pre-CPAP; on NIPPV, regular spontaneous
breaths seen in addition to mechanically assisted breaths. (C) Lamb 8 soon after transition to CPAP; initially
regular spontaneous breathing gradually slows to apnoea. RIP, respiratory inductance plethysmography;
NIPPV, nasal intermittent positive pressure ventilation; CPAP, continuous positive airway pressure.
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intubated preterm lamb to CPAP in the first hour of life. The deep nasal tube and rela-
tively leak-free experimental setup meant that the nasal positive pressure inflations
regularly resulted in appreciable chest excursion, in contrast to what is often seen in
human infants [19]. This in turn allowed sufficient ventilation to avoid early respiratory
acidosis, with PaCO2 values during NIPPV slightly better than those previously noted
with nasal high-frequency ventilation in preterm lambs of similar gestation [13]. In
some lambs, NIPPV appeared to be a potent stimulus of spontaneous respiratory effort,
possibly with a mechanism similar to Head’s paradoxical reflex [20]. This was exploited
by the use of low NIPPV rates (2 to 5 bpm) in several instances where there was recur-
rent apnoea on CPAP alone.
Transition to CPAP at around 30 min of life was associated with a significant but
short-lived respiratory acidosis and increase in oxygen requirement. This brief deterior-
ation in gas exchange did not appear to be ultimately problematic, and there were no
substantial heart rate or blood pressure changes as CPAP was established. Most animals
were on CPAP throughout the last hour of the experiment. Gas exchange at end-
experiment was satisfactory, with PaCO2 and AaDO2 values on par with pre-CPAP
readings and also with values previously noted in intubated lambs on CPAP [8]. A lon-
ger period of CPAP, and eventually weaning from CPAP, would have been possible in
nine out of the ten animals, the exception being the lamb with untreated pneumo-
thorax, which had worsening acidosis and poor oxygenation at end-experiment. Note
that pneumothorax is not an unexpected outcome in a preterm CPAP model, being
seen in as many as 9% of preterm infants on CPAP [21].
The use of caffeine and doxapram may have aided in the stimulation of regular re-
spiratory effort in our CPAP model. Both are effective for this purpose in the premature
lamb [22] and may have a synergistic effect when used together [18]. Doxapram is used
in veterinary medicine as a treatment for apnoea in preterm and asphyxiated animals,
with a relatively wide gap between therapeutic and toxic windows [23]. Nevertheless,
some unwanted neurological effects, in particular myoclonic activity, were seen after
bolus doses in some animals, emphasising the need for judicious use of this medication
in this setting.
The oesophageal balloon was an effective means of preventing gaseous abdominal
distension, previously a limiting factor to the development of a CPAP model in the
non-intubated lamb [12], and a regular complication of CPAP in preterm infants [24].
The occlusion of the oesophagus was probably of most value during NIPPV, during
which significant gastric distension may occur, especially with a long nasal tube [25].
The effective transition to CPAP via NIPPV and the relative ease of ventilation there-
after suggest that this CPAP model may be applicable in even less mature preterm
Figure 4 (See legend on next page.)
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Figure 4 Respiratory patterns (II). Representative tracings of RIP voltage (top) and airway opening
pressure (bottom) during the experiment. (A) Lamb 7 at 35 min after first attempt at CPAP transition; initial
apnoea is followed by prompt return of spontaneous respiratory effort after reinstitution of NIPPV. (B) Lamb 8
at 30 min post-CPAP; NIPPV does not result in mechanically assisted breaths but does interfere with the
cadence of spontaneous breathing. (C) Lamb 7 at 150 min; comfortably breathing on CPAP alone, spontaneous
respiratory rate 65/min, PaCO2 44 mm Hg and FiO2 0.21. See Figure 3 legend for abbreviations.
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more faithfully replicate the surfactant deficiency seen in very preterm infants. At least
in intubated lambs, the maturity of the surfactant system has been found to be an im-
portant factor in determining whether transition to CPAP is possible [6]. This observa-
tion can potentially now be re-examined in a non-intubated preterm lamb using less
invasive methods of surfactant delivery [2,3].
Several limitations of our study of the preterm lamb on CPAP are evident. Animals
were in a narrow range of gestation, and all were managed with the same treatment
protocol, including administration of surfactant. Respiratory support only continued for
150 min after CPAP, and no attempt at weaning from CPAP was made. Finally, we have
not made any physiological or histological comparison with lambs intubated and venti-
lated from the outset. These studies, and many others examining different research
questions related to the premature infant on NIPPV and CPAP, should be possible with
this model.Conclusions
In conclusion, with the use of nasal IPPV, oesophageal occlusion and respiratory stimu-
lants, non-intubated very preterm lambs can be effectively transitioned to nasal CPAP
soon after birth. This model will be valuable for further research investigating non-
invasive respiratory support after premature birth.Table 1 NIPPV requirements and respiratory rates
Time NIPPV used Set NIPPV rate Mechanically
assisted RR
Spontaneous RR Total RR
n (%) (inflations/min)a (breaths/min) (breaths/min) (breaths/min)
Initial 10 (100) 30 ± 0 25 ± 9.2 24 ± 24 50 ± 20
Pre-CPAP 10 (100) 30 ± 0 26 ± 8.9 21 ± 31 47 ± 25
15 min post-CPAP 5 (50) 15 ± 14 3.9 ± 5.9b 39 ± 30 43 ± 30
30 min post-CPAP 6 (60) 23 ± 11 14 ± 14 34 ± 30 48 ± 25
45 min post-CPAP 6 (60) 26 ± 10 14 ± 14 39 ± 32 52 ± 22
60 min post-CPAP 4 (40) 22 ± 20 8.8 ± 16b 41 ± 30 50 ± 22
90 min post-CPAP 3 (30) 33 ± 6.0 8.9 ± 14 49 ± 30 58 ± 25
120 min post-CPAP 1 (10) 46 ± 0 4.6 ± 15b 55 ± 21b 60 ± 20
150 min post-CPAP 2 (20) 31 ± 1.4 4.7 ± 10b 56 ± 24b 61 ± 15
Values for NIPPV requirements and respiratory rates at each time point; mean ± SD unless stated. Respiratory rate (RR)
counted in a 2-min window; reported values are for all lambs, whether or not receiving NIPPV. See text for definition of
mechanically assisted breath. aReported value for set NIPPV rate includes only lambs receiving NIPPV. bDiffers from
pre-CPAP value, P < 0.05, ANOVA with Dunnett’s post hoc test.
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